ObjectivesThis study was devised to describe the different cardiac magnetic resonance (CMR) appearances in light chain amyloid (AL) and transthyretin-related amyloidosis (ATTR).BackgroundCMR is increasingly used to investigate patients with suspected amyloidosis. Global subendocardial late gadolinium enhancement (LGE) has been reported as typical of AL amyloidosis, whereas different patterns have been noted in ATTR amyloidosis.MethodsWe performed de novo analyses on original DICOM magnetic resonance imaging in 46 patients with cardiac AL amyloidosis and 51 patients with ATTR type who had been referred to a specialist amyloidosis center between 2007 and 2012 after CMR. Histological examination was performed in all cases, with immunohistochem...
BACKGROUND: The prognosis and treatment of the 2 main types of cardiac amyloidosis, immunoglobulin l...
ObjectivesThis study sought to explore the potential role of noncontrast myocardial T1 mapping for d...
Diagnoses of amyloidosis, particularly transthyretin amyloid cardiomyopathy (ATTR-CM), are steadily ...
ObjectivesThis study was devised to describe the different cardiac magnetic resonance (CMR) appearan...
Aims To compare the baseline cardiovascular characteristics of immunoglobulin light-chain (AL) and a...
Early diagnosis is crucial for the improvement of outcomes of patients with cardiac amyloidosis (CA)...
Background: Diagnosis of cardiac involvement in amyloid A (AA) amyloidosis is challenging since AA a...
Systemic amyloidosis is a rare, heterogenous group of diseases characterized by extracellular infilt...
BACKGROUND: Few studies have analyzed the clinical and echocardiographic differences between light-c...
Background. Late gadolinium enhancement (LGE) technique is currently used for the diagnosis of cardi...
Objectives: This study sought to explore the potential role of noncontrast myocardial T1 mapping for...
Cardiac amyloidosis of transthyretin fibril protein (ATTR) type is an infiltrative cardiomyopathy ch...
BACKGROUND: Cardiac transthyretin amyloidosis (ATTR) is an increasingly recognized cause of heart fa...
OBJECTIVES: This study sought to explore the potential role of noncontrast myocardial T1 mapping for...
Background - : Immunoglobulin amyloid light-chain (AL)-related cardiac amyloidosis (CA) has a worse ...
BACKGROUND: The prognosis and treatment of the 2 main types of cardiac amyloidosis, immunoglobulin l...
ObjectivesThis study sought to explore the potential role of noncontrast myocardial T1 mapping for d...
Diagnoses of amyloidosis, particularly transthyretin amyloid cardiomyopathy (ATTR-CM), are steadily ...
ObjectivesThis study was devised to describe the different cardiac magnetic resonance (CMR) appearan...
Aims To compare the baseline cardiovascular characteristics of immunoglobulin light-chain (AL) and a...
Early diagnosis is crucial for the improvement of outcomes of patients with cardiac amyloidosis (CA)...
Background: Diagnosis of cardiac involvement in amyloid A (AA) amyloidosis is challenging since AA a...
Systemic amyloidosis is a rare, heterogenous group of diseases characterized by extracellular infilt...
BACKGROUND: Few studies have analyzed the clinical and echocardiographic differences between light-c...
Background. Late gadolinium enhancement (LGE) technique is currently used for the diagnosis of cardi...
Objectives: This study sought to explore the potential role of noncontrast myocardial T1 mapping for...
Cardiac amyloidosis of transthyretin fibril protein (ATTR) type is an infiltrative cardiomyopathy ch...
BACKGROUND: Cardiac transthyretin amyloidosis (ATTR) is an increasingly recognized cause of heart fa...
OBJECTIVES: This study sought to explore the potential role of noncontrast myocardial T1 mapping for...
Background - : Immunoglobulin amyloid light-chain (AL)-related cardiac amyloidosis (CA) has a worse ...
BACKGROUND: The prognosis and treatment of the 2 main types of cardiac amyloidosis, immunoglobulin l...
ObjectivesThis study sought to explore the potential role of noncontrast myocardial T1 mapping for d...
Diagnoses of amyloidosis, particularly transthyretin amyloid cardiomyopathy (ATTR-CM), are steadily ...